Skip to contentJ
JRSIS HEALTH CARE Corp
J
JRSSJRSIS HEALTH CARE Corp Q2 2024 · 10-Q
Revenue$597.40K$597.40K+77.1% vs Q2 2023 Net Income-$102.44K-$102.44KN/M vs Q2 2023 EPS Diluted-$0.00-$0.00N/M vs Q2 2023 Gross Profit$186,112+369.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
JRSIS HEALTH CARE Corp · CIK 1597892 · Engraved from SEC EDGAR
Operating Cash Flowderived-$268,858N/M Margins · derivedGross margin31.2%+19.4 pt vs Q2 2023
Operating margin-19.9%+17.9 pt vs Q2 2023
Net margin-17.1%+14.3 pt vs Q2 2023
ended Jun 30, 2024 · filed Sep 5, 2024 · 67 d after period end